FDA 483 - Granules Pharmaceuticals Inc. - January 28, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Granules Pharmaceuticals Inc, a drug manufacturer in Chantilly, VA, was cited with three observations during an FDA inspection. The firm failed to consistently follow established production and process control procedures, specifically regarding metal detection challenges. Additionally, the inspection revealed inadequate record-keeping for equipment cleaning and a lack of established and followed procedures for the cleaning and maintenance of equipment and the facility, leading to unsanitary conditions.
ID · 47bd023e-5880-46d4-9c5a-5d1a6a31f0be